Saquinavir Mesylate Articles

New label warnings on use of Roche’s HIV drug Invirase together with Abbott’s Norvir imposed by US FDA; EMEA calls for lower starting dose

22 October 2010

UK’s MHRA advises on rosiglitazone cardiovascular risk, saquinavir contraindications

11 August 2010

Europe's CHMP to review of ARBs for possible cancer risk; starts Invirase assessment

29 June 2010

US FDA warns Lilly on insulin API manufacturing violations and Roche and Abbott over HIV combo drug concerns

24 February 2010

Tamiflu and weak dollar impact Roche sales but cancer drug turnover strong

28 April 2008

Roche's Invirase non-inferior to Kaletra

5 November 2007

Invirase lowers HIV levels with better lipid profile

20 November 2006

Roche's new Invirase version OKd in EU

6 June 2005

Tipranavir more effective than lopinavir in HIV, study finds

7 March 2005

Roche's Invirase 500mg gets US approval

10 January 2005

Pharma told: freeze US HIV/AIDS and hep C Rx prices, cut those of Norvir and Fuzeon

25 October 2004

Increasing HIV survival rates present new treatment challenges; Datamonitor report

4 October 2004

Roche cuts HIV/AIDS drug prices again

14 June 2004

Roche claims more than 12 products in pipeline with blockbuster potential

10 May 2004

Roche and Trimeris' HIV drug Fuzeon cleared on schedule by US FDA

24 March 2003

Roche "no profit" HIV/ AIDS drug deal widens

24 February 2003

CPMP backs new schedule for Roche HIV drug

24 June 2002

Roche upbeat on pipeline despite problems with Trocade and Bonviva

13 April 2000

-Roche launches Fortovase in UK

15 April 1999

Roche Reports 32% Surge In 9 Months 1998 Sales

12 October 1998

EU OK For Fortovase In HIV Infection

1 September 1998

Abbott Reports Production Problems For Norvir

28 July 1998

Xenical Recommended For Approval By CPMP

16 April 1998

Roche Sales Soar In 1st Quarter 1998

7 April 1998

Expanded Warnings For J&J's Hismanal

11 February 1998

Global Anti-HIV Market To Top $5 Billion In 2005

21 January 1998

HIVID Combination Gets EU Approval

4 December 1997

Can Protease Inhibitor Resistance Be Combatted?

4 November 1997

Roche's Invirase Confers Survival Benefit

20 October 1997

Drug Combo Targets HIV In CNS

16 October 1997

NDA Filed For New Soft-Gel Saquinavir

9 October 1997

Solid First Half At Roche As Posicor Is Approved

16 July 1997

Roche Shows Three HIV Drugs Cut AIDS Onset

26 June 1997

Roche Files For New Invirase Formulation

19 May 1997

Investors Impressed With Glaxo Wellcome Pipeline

12 May 1997

First-Quarter Sales At Roche Up 18%

21 April 1997

Saquinavir Subject To MDR Pump Clearance

17 March 1997

Roche Enters New Product Phase With Bright Prospects

17 February 1997

Roche Impresses At Analysts' Meeting

17 February 1997

Israel: Updating The Drug Basket, Funding Innovation

10 February 1997

Promise With Agouron's Viracept & Roche's Invirase

3 February 1997

Roche's 1996 Sales Ahead Of Expectations

27 January 1997

Spanish Health Care Spending On AIDS

13 January 1997

EU CPMP October Meeting

28 October 1996

New HIV Drugs Raise Funding Specter In UK

28 October 1996

Roche Posts 10% 9 Mths Sales Gain

21 October 1996

UK Launch For Roche's Invirase

21 October 1996

Crixivan And Invirase Cleared In EU For HIV

14 October 1996

First Launch Of Boehringer Ingelheim's Nevirapine

2 September 1996

1996 First-Half Sales In Line At Roche

22 July 1996

Combining Protease Inhibitors In HIV; 1st Data

22 July 1996

Nevirapine Gains Fast-Track Approval In USA For HIV

8 July 1996

EUROPE STOCK COMMENT

1 July 1996

CPMP Positive On Roche's Invirase

1 July 1996

Positive Opinion From CPMP For Abbott's Norvir

3 June 1996

Roche Launches Invirase In Canada

8 April 1996

Merck's Crixivan Is Third Protease Inhibitor Cleared

25 March 1996

Norvir Launch Soon As FDA Clears 2nd Protease Inhibitor

11 March 1996

Brussels Probes Roche Austrian "Subsidy"

4 March 1996

Moves In HIV Therapy As FDA Panel Delivers Verdicts

4 March 1996

Ritonavir Cuts HIV Deaths By Almost Half, Says Study

12 February 1996

Triple Therapies For HIV Provide Encouraging Data

5 February 1996

NCEs In 1995: A Good Range Of Novel Drugs

29 January 1996

Prix Galien For Roche And Glaxo Wellcome

29 January 1996

Agouron Pushes Viracept Towards Pivotal Trials

15 January 1996

First Launch Of Protease Inhibitor Raises Cost Concerns

18 December 1995

** STOP PRESS ** First Approval For Protease Inhibitor To Treat AIDS

4 December 1995

...And Roche Gets Recommendation For Invirase

13 November 1995

Fast Growth Forecast For Antivirals

30 October 1995

Strong Pharma Growth Offsets Currency At Roche

16 October 1995

FDA Antiviral DAC review HIV treatments

9 October 1995

Agouron's Viracept: Pilot Phase II Data

25 September 1995

Roche Files NDA In USA For Invirase

11 September 1995

Expanded Access For Merck's Crixivan

24 July 1995

Roche's Invirase Made Available In USA

3 July 1995

Expanded Access Urged For Protease Inhibitors

13 March 1995

Showing 1-76 of 76 articles

Go to beginningPrevious
  • 1
NextGo to end